JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Visa
V
$677B
| $1.94B | 0.26% |
9,326,445
-1,092,460
| -10% | -$220M |
2013 Q2
38 quarters
|
|
102
General Dynamics
GD
$89.3B
| $1.92B | 0.25% |
7,743,312
+624,091
| +9% | +$152M |
2013 Q2
38 quarters
|
|
103
Mondelez International
MDLZ
$74.3B
| $1.91B | 0.25% |
28,706,758
-1,765,977
| -6% | -$112M |
2013 Q2
38 quarters
|
|
104
Verizon
VZ
$191B
| $1.9B | 0.25% |
48,168,949
-5,050,871
| -9% | -$190M |
2013 Q2
38 quarters
|
|
|
105
Union Pacific
UNP
$165B
| $1.88B | 0.25% |
9,074,382
+3,513,949
| +63% | +$721M |
2013 Q2
38 quarters
|
|
106
Accenture
ACN
$122B
| $1.86B | 0.25% |
6,982,304
+226,965
| +3% | +$62.8M |
2013 Q2
38 quarters
|
|
107
Linde
LIN
$221B
| $1.86B | 0.25% |
5,709,061
-63,486
| -1% | -$19.9M |
2018 Q4
16 quarters
|
|
108
Dover
DOV
$25.5B
| $1.74B | 0.23% |
12,858,526
-408,443
| -3% | -$54.3M |
2013 Q2
38 quarters
|
|
109
iShares MSCI Japan ETF
EWJ
$23.6B
| $1.7B | 0.22% |
31,241,560
+120,869
| +0.4% | +$6.36M |
2013 Q2
38 quarters
|
|
110
iShares MSCI EAFE ETF
EFA
$76.8B
| $1.63B | 0.21% |
24,802,102
-7,520,606
| -23% | -$471M |
2013 Q2
38 quarters
|
|
111
Freeport-McMoran
FCX
$103B
| $1.62B | 0.21% |
42,599,298
+6,083,169
| +17% | +$213M |
2013 Q2
38 quarters
|
|
112
Booking.com
BKNG
$119B
| $1.6B | 0.21% |
19,814,425
-61,625
| -0.3% | -$4.68M |
2013 Q2
38 quarters
|
|
113
Vertex Pharmaceuticals
VRTX
$128B
| $1.59B | 0.21% |
5,490,408
+630,721
| +13% | +$192M |
2013 Q2
38 quarters
|
|
114
Lam Research
LRCX
$435B
| $1.58B | 0.21% |
37,600,790
-1,141,220
| -3% | -$47.7M |
2013 Q2
38 quarters
|
|
115
Walmart Inc
WMT
$827B
| $1.56B | 0.21% |
33,063,849
-1,856,994
| -5% | -$88.2M |
2013 Q2
38 quarters
|
|
116
Medtronic
MDT
$110B
| $1.56B | 0.21% |
20,022,246
-1,109,473
| -5% | -$89.9M |
2013 Q2
38 quarters
|
|
117
iShares Russell 1000 Growth ETF
IWF
$130B
| $1.55B | 0.2% |
28,984,992
-1,169,692
| -4% | -$64.3M |
2013 Q2
38 quarters
|
|
118
Chubb
CB
$128B
| $1.55B | 0.2% |
7,029,941
-124,595
| -2% | -$25.9M |
2013 Q2
38 quarters
|
|
119
Automatic Data Processing
ADP
$102B
| $1.54B | 0.2% |
6,439,821
+1,388,221
| +27% | +$341M |
2013 Q2
38 quarters
|
|
120
Northrop Grumman
NOC
$67.9B
| $1.53B | 0.2% |
2,807,338
-775,334
| -22% | -$404M |
2013 Q2
38 quarters
|
|
121
Synopsys
SNPS
$93.9B
| $1.53B | 0.2% |
4,782,985
-79,696
| -2% | -$24.9M |
2013 Q2
38 quarters
|
|
122
Baker Hughes
BKR
$55.6B
| $1.49B | 0.2% |
50,545,317
+501,606
| +1% | +$13.8M |
2017 Q3
21 quarters
|
|
123
Marriott International
MAR
$93.6B
| $1.49B | 0.2% |
9,998,876
+1,216,351
| +14% | +$187M |
2013 Q2
38 quarters
|
|
124
iShares 3-7 Year Treasury Bond ETF
IEI
$17.2B
| $1.49B | 0.2% |
12,928,905
+664,769
| +5% | +$76.2M |
2013 Q2
38 quarters
|
|
125
Mercado Libre
MELI
$86B
| $1.47B | 0.19% |
1,732,788
+192,111
| +12% | +$171M |
2014 Q3
33 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.